Published in J Bacteriol on September 01, 2006
Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG. Infect Immun (2007) 1.64
Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev (2009) 1.59
Subversion of host recognition and defense systems by Francisella spp. Microbiol Mol Biol Rev (2012) 1.40
An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine (2008) 1.35
Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS. Infect Immun (2009) 1.25
Macrophage replication screen identifies a novel Francisella hydroperoxide resistance protein involved in virulence. PLoS One (2011) 1.14
Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS). DNA Cell Biol (2008) 1.14
Francisella tularensis antioxidants harness reactive oxygen species to restrict macrophage signaling and cytokine production. J Biol Chem (2010) 1.12
Mechanisms of Francisella tularensis intracellular pathogenesis. Cold Spring Harb Perspect Med (2013) 1.10
Reciprocal analysis of Francisella novicida infections of a Drosophila melanogaster model reveal host-pathogen conflicts mediated by reactive oxygen and imd-regulated innate immune response. PLoS Pathog (2010) 1.06
Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species. J Bacteriol (2009) 1.05
Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model. Antimicrob Agents Chemother (2009) 1.03
Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress. Infect Immun (2008) 1.03
Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia. J Leukoc Biol (2011) 0.98
Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response. J Biol Chem (2012) 0.97
Genome-wide saturation mutagenesis of Burkholderia pseudomallei K96243 predicts essential genes and novel targets for antimicrobial development. MBio (2014) 0.94
Environmental adaptation of Francisella tularensis. Microbes Infect (2009) 0.93
Vaccines against tularemia. Hum Vaccin (2009) 0.91
TetR-based gene regulation systems for Francisella tularensis. Appl Environ Microbiol (2012) 0.91
Genetic manipulation of francisella tularensis. Front Microbiol (2011) 0.91
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine (2011) 0.90
NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis. Mol Microbiol (2012) 0.90
Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis. J Bacteriol (2009) 0.88
Glutamate utilization couples oxidative stress defense and the tricarboxylic acid cycle in Francisella phagosomal escape. PLoS Pathog (2014) 0.88
Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity. Infect Drug Resist (2014) 0.87
Rationally designed tularemia vaccines. Expert Rev Vaccines (2009) 0.87
Systems approach to investigating host-pathogen interactions in infections with the biothreat agent Francisella. Constraints-based model of Francisella tularensis. BMC Syst Biol (2010) 0.87
Live attenuated tularemia vaccines: recent developments and future goals. Vaccine (2013) 0.86
Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis. Infect Immun (2012) 0.86
Identification of a live attenuated vaccine candidate for tularemia prophylaxis. PLoS One (2013) 0.85
From the Outside-In: The Francisella tularensis Envelope and Virulence. Front Cell Infect Microbiol (2015) 0.85
EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice. Mol Microbiol (2014) 0.84
Futile cycling increases sensitivity toward oxidative stress in Escherichia coli. Metab Eng (2015) 0.80
Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines. J Biol Chem (2015) 0.79
Preclinical testing of a vaccine candidate against tularemia. PLoS One (2015) 0.77
Multifaceted effects of Francisella tularensis on human neutrophil function and lifespan. Immunol Rev (2016) 0.76
Elucidation of a mechanism of oxidative stress regulation in Francisella tularensis live vaccine strain. Mol Microbiol (2016) 0.76
Detection, distribution and characterization of novel superoxide dismutases from Yersinia enterocolitica Biovar 1A. PLoS One (2013) 0.75
Complete proteome of a quinolone-resistant Salmonella Typhimurium phage type DT104B clinical strain. Int J Mol Sci (2014) 0.75
Lack of OxyR and KatG Results in Extreme Susceptibility of Francisella tularensis LVS to Oxidative Stress and Marked Attenuation In vivo. Front Cell Infect Microbiol (2017) 0.75
The FinR-regulated essential gene fprA, encoding ferredoxin NADP+ reductase: Roles in superoxide-mediated stress protection and virulence of Pseudomonas aeruginosa. PLoS One (2017) 0.75
Using host-pathogen protein interactions to identify and characterize Francisella tularensis virulence factors. BMC Genomics (2015) 0.75
Iron and Virulence in Francisella tularensis. Front Cell Infect Microbiol (2017) 0.75
Glycosylation of a Capsule-Like Complex (CLC) by Francisella novicida Is Required for Virulence and Partial Protective Immunity in Mice. Front Microbiol (2017) 0.75
Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem (1971) 28.59
Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? EMBO J (1986) 7.90
The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet (2005) 6.22
Superoxide dismutase from escherichia coli B. A new manganese-containing enzyme. J Biol Chem (1970) 5.10
Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci U S A (1996) 4.29
Mutagenesis and stress responses induced in Escherichia coli by hydrogen peroxide. J Bacteriol (1987) 3.94
Role of oxidants in microbial pathophysiology. Clin Microbiol Rev (1997) 3.78
A method for allelic replacement in Francisella tularensis. FEMS Microbiol Lett (2003) 3.19
Paraquat and Escherichia coli. Mechanism of production of extracellular superoxide radical. J Biol Chem (1979) 2.82
Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun (1999) 2.69
Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect Immun (2001) 1.94
Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J Immunol (1992) 1.70
Role and regulation of the superoxide dismutases of Staphylococcus aureus. Microbiology (2003) 1.57
The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice. Infect Immun (2005) 1.55
Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect Immun (2001) 1.43
The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages. Microbes Infect (2005) 1.41
Microbial superoxide dismutases. Adv Genet (1989) 1.35
Transcriptional and post-transcriptional regulation by nickel of sodN gene encoding nickel-containing superoxide dismutase from Streptomyces coelicolor Müller. Mol Microbiol (1998) 1.20
Identification and subcellular localization of a novel Cu,Zn superoxide dismutase of Mycobacterium tuberculosis. FEBS Lett (1998) 1.19
The iron superoxide dismutase of Legionella pneumophila is essential for viability. J Bacteriol (1994) 1.18
Endogenous superoxide dismutase levels regulate iron-dependent hydroxyl radical formation in Escherichia coli exposed to hydrogen peroxide. J Bacteriol (1998) 1.13
Determination of microbial damage caused by oxygen free radicals, and the protective role of superoxide dismutase. Methods Enzymol (1984) 1.12
Increased expression of periplasmic Cu,Zn superoxide dismutase enhances survival of Escherichia coli invasive strains within nonphagocytic cells. Infect Immun (2000) 1.12
The role of two periplasmic copper- and zinc-cofactored superoxide dismutases in the virulence of Salmonella choleraesuis. Microbiology (2002) 1.07
Transcriptional and translational regulation of the marRAB multiple antibiotic resistance operon in Escherichia coli. Mol Microbiol (2004) 1.03
Expression and regulation of the sodF gene encoding iron- and zinc-containing superoxide dismutase in Streptomyces coelicolor Müller. J Bacteriol (1998) 0.98
Lipid peroxidation in brain homogenates: the role of iron and hydroxyl radicals. J Neurochem (1997) 0.97
Free radicals, lipid peroxidation, and cell damage. Lancet (1984) 0.95
In vivo and in vitro analysis of Bordetella pertussis catalase and Fe-superoxide dismutase mutants. FEMS Microbiol Lett (1996) 0.92
[Superoxide dismutase activity in representatives of the genus Francisella]. Zh Mikrobiol Epidemiol Immunobiol (1992) 0.81
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51
Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem (2002) 4.48
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol (2002) 3.93
Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med (2008) 3.67
Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect Immun (2006) 2.12
Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med (2004) 2.02
Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain. Infect Immun (2005) 1.97
Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol (2006) 1.96
Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem (2005) 1.88
Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. J Immunol (2007) 1.85
Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun (2007) 1.64
Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol (2007) 1.61
Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis (2007) 1.58
Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect Immun (2007) 1.57
Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J Immunol (2003) 1.53
Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections. J Immunol (2010) 1.52
Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res (2007) 1.52
Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol Rev (2008) 1.48
Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS. Cell Immunol (2005) 1.47
Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci U S A (2006) 1.45
Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J Immunol (2010) 1.38
Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. J Immunol (2008) 1.36
Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proc Natl Acad Sci U S A (2011) 1.36
NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 1.35
An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine (2008) 1.35
Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res (2003) 1.27
Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro. Infect Immun (2008) 1.25
Two DHH subfamily 1 proteins in Streptococcus pneumoniae possess cyclic di-AMP phosphodiesterase activity and affect bacterial growth and virulence. J Bacteriol (2013) 1.24
Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis. Anticancer Agents Med Chem (2011) 1.24
A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J Virol (2010) 1.22
Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases. PLoS One (2011) 1.20
Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. Infect Immun (2003) 1.19
Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity. Int Immunopharmacol (2003) 1.16
Cyclic di-AMP impairs potassium uptake mediated by a cyclic di-AMP binding protein in Streptococcus pneumoniae. J Bacteriol (2013) 1.16
Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS). DNA Cell Biol (2008) 1.14
Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. J Cell Physiol (2010) 1.12
Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease. J Immunol (2005) 1.11
Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic Biol Med (2008) 1.11
Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide- and Escherichia coli-induced systemic inflammation. Am J Physiol Regul Integr Comp Physiol (2012) 1.10
Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain. Biochem J (2003) 1.07
Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation. J Biol Chem (2011) 1.07
CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance. PLoS Pathog (2009) 1.06
Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species. J Bacteriol (2009) 1.05
DPI induces mitochondrial superoxide-mediated apoptosis. Free Radic Biol Med (2003) 1.05
Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest (2010) 1.03
Rapid differentiation of Mycobacterium bovis and Mycobacterium tuberculosis based on a 12.7-kb fragment by a single tube multiplex-PCR. Vet Microbiol (2005) 1.03
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants. Sci Rep (2011) 1.03
The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens. Tissue Eng (2002) 1.02
Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One (2011) 1.02
Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J Immunol (2009) 1.01
Redox-dependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs. J Biol Chem (2006) 0.99
Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia. J Leukoc Biol (2011) 0.98
An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J Immunol (2004) 0.98
Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response. J Biol Chem (2012) 0.97
Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity. PLoS One (2013) 0.97
Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection. J Immunol (2014) 0.97
Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl Immunol (2002) 0.97
Mitochondrial localization of catalase provides optimal protection from H2O2-induced cell death in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2005) 0.96
Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. J Virol (2003) 0.96
Repression of inflammasome by Francisella tularensis during early stages of infection. J Biol Chem (2013) 0.95
Potent anti-tumor effects of an active site mutant of human manganese-superoxide dismutase. Evolutionary conservation of product inhibition. J Biol Chem (2003) 0.95
Immune response to small intestinal submucosa (surgisis) implant in humans: preliminary observations. J Invest Surg (2007) 0.93
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine (2011) 0.90
The vitamin B₆ biosynthesis pathway in Streptococcus pneumoniae is controlled by pyridoxal 5'-phosphate and the transcription factor PdxR and has an impact on ear infection. J Bacteriol (2013) 0.90
GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages. Infect Immun (2010) 0.90
Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis. J Bacteriol (2009) 0.88
Manganese superoxide dismutase inactivation during Fas (CD95)-mediated apoptosis in Jurkat T cells. Free Radic Biol Med (2006) 0.88
Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract. Infect Immun (2011) 0.87
Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection. Infect Immun (2013) 0.87
Serotonin-induced MMP-13 production is mediated via phospholipase C, protein kinase C, and ERK1/2 in rat uterine smooth muscle cells. J Biol Chem (2002) 0.87
Redox control of the senescence regulator interleukin-1α and the secretory phenotype. J Biol Chem (2013) 0.86
Cyclic pressure affects osteoblast functions pertinent to osteogenesis. Ann Biomed Eng (2003) 0.86
Acquisition of the metastatic phenotype is accompanied by H2O2-dependent activation of the p130Cas signaling complex. Mol Cancer Res (2013) 0.86
Mucosal B cell deficiency in IgA-/- mice abrogates the development of allergic lung inflammation. J Immunol (2005) 0.86
Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media. Vaccine (2006) 0.85
Identification of a live attenuated vaccine candidate for tularemia prophylaxis. PLoS One (2013) 0.85
Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice. J Clin Invest (2009) 0.85
Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue. Vaccine (2008) 0.84
EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice. Mol Microbiol (2014) 0.84
Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. J Virol (2003) 0.84
Deletion of arcD in Streptococcus pneumoniae D39 impairs its capsule and attenuates virulence. Infect Immun (2013) 0.84
Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia. PLoS One (2013) 0.83
Enhanced microdialysis relative recovery of inflammatory cytokines using antibody-coated microspheres analyzed by flow cytometry. Anal Chem (2004) 0.83
Antistaphylococcal nanocomposite films based on enzyme-nanotube conjugates. ACS Nano (2010) 0.83
Mouse models for the study of mucosal vaccination against otitis media. Vaccine (2008) 0.83